Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis. - Wikidata - awgldk - TriplyDB

Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.

Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.

http://www.wikidata.org/entity/Q35067307

about

High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population.Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance.

P2860

Q36979735-B8AB9221-C97D-4F2F-AC6B-FB93793A863E Q47094381-84CC1102-D54E-45C4-BA68-023A2A42E182

P2860

Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.

http://www.wikidata.org/entity/Q35067307

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Evaluation of relapse-free sur ...... entric retrospective analysis.

@ast

Evaluation of relapse-free sur ...... entric retrospective analysis.

@en

type

label

Evaluation of relapse-free sur ...... entric retrospective analysis.

@ast

Evaluation of relapse-free sur ...... entric retrospective analysis.

@en

prefLabel

Evaluation of relapse-free sur ...... entric retrospective analysis.

@ast

Evaluation of relapse-free sur ...... entric retrospective analysis.

@en

P1433

Q35067307-EADA006D-E0BE-4B1F-9798-ECA341A20077

P1476

Q35067307-4AA850A3-D4A6-46F3-9D47-C43D6B6B85D0

P2093

Q35067307-01C8E8F2-D975-46C2-B038-E6F95C19D8D2

Q35067307-28574E0A-312D-4BDB-8DB4-045A5E193DC6

Q35067307-4C327C83-5898-4BEE-896A-28FFEB88F05A

Q35067307-5D44B04B-16DF-4397-9ACB-D9998E622438

Q35067307-664BD6AC-8E00-45D6-B556-597A2BA32A23

Q35067307-672414FB-9B44-45A5-AC47-C8081322731D

Q35067307-9251B86A-D470-45E2-8A49-68589D7C3D7E

Q35067307-C6A9B673-6F13-40D8-A36C-8B78EF4F9798

Q35067307-C6CA7A5B-35C2-42DD-85C5-2A1D63D04099

Q35067307-D9D4E971-59E3-48F4-858E-8A8BA37BDE80

P2860

Q35067307-0444558B-B34E-468A-ACB7-E3A08B833D41

Q35067307-0AAFEF7B-3C71-472F-A6B5-5B65DCAC4F30

Q35067307-0B4E5ED5-C424-42D2-97FD-EC4CF9E057D6

Q35067307-0FB5CCA9-B5F8-4C5C-8E45-12FE8040E257

Q35067307-1C02CEB8-CEF7-41BE-B3A4-757372FC6B0E

Q35067307-23315710-3CAB-4E9A-8322-2C8B5A6A1BC6

Q35067307-2505BBF5-11E9-4FB2-99E0-F24726E0BA18

Q35067307-25911D31-5C81-4F2A-9AFD-908F0008CFB4

Q35067307-291BBA63-B411-4202-89DE-475051B654B1

Q35067307-3456FA7B-0DD7-4695-9B65-6BCE41F1D320

P304

Q35067307-719D3197-05CF-4AD1-947E-B0E67C611DFD

P31

Q35067307-A9CF9C6F-30C7-46FC-A96E-D414990BAEC8

P356

Q35067307-ED43A06A-CABD-4B6B-B051-DA305EEFFB2F

P407

Q35067307-0244FA74-9D2C-4B6D-A887-6A79B2FF6CD9

P433

Q35067307-A9BED85C-662C-4655-84BE-8C5365A8405F

P478

Q35067307-D4C4825D-F3A2-414A-9271-3533163D47E3

P50

Q35067307-69DA5C4D-B093-405F-8AB0-D2565665254B

P577

Q35067307-2E6D3B64-9E68-479A-B01C-A7BAC8D407DD

P5875

Q35067307-888B635D-DB8E-4CCD-B6B7-078F347EC7CE

P698

Q35067307-CB0B80E2-0545-43F7-BF78-DBE5E581F5AD

P932

Q35067307-B1EEDA7A-8C82-4DFE-9AFC-0F8E1DBB845C

P356

JOURNAL.PONE.0080188

P1433

P1476

Evaluation of relapse-free sur ...... entric retrospective analysis.

@en

P2093

Agnese Fabbri

http://www.w3.org/2001/XMLSchema#string

Domenico Corsi

http://www.w3.org/2001/XMLSchema#string

Donatello Gemma

http://www.w3.org/2001/XMLSchema#string

Enzo Ruggeri

http://www.w3.org/2001/XMLSchema#string

Fabrizio Ciancola

http://www.w3.org/2001/XMLSchema#string

Germano Zampa

http://www.w3.org/2001/XMLSchema#string

Lorena Rossi

http://www.w3.org/2001/XMLSchema#string

Maria G Diodoro

http://www.w3.org/2001/XMLSchema#string

Raffaello Mancini

http://www.w3.org/2001/XMLSchema#string

Roberta Grande

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant Therapy for completely resected Stage II Colon Cancer

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

P304

e80188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0080188

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Isabella Sperduti

P577

2013-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259337358

http://www.w3.org/2001/XMLSchema#string

P698

24339871

http://www.w3.org/2001/XMLSchema#string

P932

3855068

http://www.w3.org/2001/XMLSchema#string